MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Characterizing the genetic architecture of Parkinson’s disease in Latinos

D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Oliva, L. Torres, M. Inca-Martinez, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Lopes Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O’Connor, I. Mata (Baltimore, MD, USA)

Meeting: MDS Virtual Congress 2020

Abstract Number: 488

Keywords: Alpha-synuclein, Parkinsonism

Category: Parkinson's Disease: Genetics

Objective: By performing the first genome-wide association study (GWAS) of Parkinson’s disease (PD) in Latinos, we seek to interrogate the genetic architecture of PD in a South American cohort. [1]

Background: PD is the fastest-growing neurodegenerative disease with an increasing burden on healthcare systems worldwide . Despite its prevalence in all ethnic groups, large-scale studies of genetic variation conferring PD risk have been limited to subjects of European and East Asian descent. We conduct the first GWAS of PD in South America, characterize the linkage disequilibrium (LD) structure of risk variants in SNCA, and perform a replication of GWAS-significant variants identified by Nalls et al. [2]

Method: We genotyped 1497 subjects (807 PD cases) from the Latin American Research Consortium on the Genetics of PD (LARGE-PD) with the MEGA chip from Illumina, followed by standard quality control and imputation using the Trans-omics for Precision Medicine (TOPMed) imputation server. We tested variants for association with PD using a generalized linear mixed model as implemented in the GENESIS R package, adjusting for age, sex, the first 5 PCs, and relatedness. For the replication of variants found by Nalls et al., we employed the unrelated subset of LARGE-PD and logistic regression in PLINK.

Results: We found two loci with genome-wide significance (p-value < 5×10-08), one in chromosome 3 near NRROS and one in chromosome 4 in SNCA. The chromosome 3 result is driven by the Peruvian subset of our cohort and is likely of Amerindian origin; chromosome 4 locus is well-characterized in the PD literature. Significant LD is observed between GWAS-significant SNCA variants and is higher overall in the Peruvian subset. Out of the 84 variants we tested from Nalls et al., 69 were concordant in their direction of effect and 11 were nominally significant. One variant in SNCA, rs356182, replicated and is genome-wide significant in our primary GWAS.

Conclusion: We affirmed the importance of SNCA, and in particular rs356182, to PD etiology in South America and identified a possible population-specific risk variant near NRROS, a gene involved in microglial function. The NRROS result needs to be replicated in an independent cohort with significant Native American ancestry. The overall concordance between the results of Nalls et al. and our replication indicate similarities in genetic architecture.

References: [1] Submitted on behalf of the Latin American Research Consortium on the Genetics of PD (LARGE-PD) [2] Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18(12):1091-1102. doi:10.1016/S1474-4422(19)30320-5

To cite this abstract in AMA style:

D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Oliva, L. Torres, M. Inca-Martinez, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Lopes Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O’Connor, I. Mata. Characterizing the genetic architecture of Parkinson’s disease in Latinos [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/characterizing-the-genetic-architecture-of-parkinsons-disease-in-latinos/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/characterizing-the-genetic-architecture-of-parkinsons-disease-in-latinos/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley